Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.
| Current Price | ₹602.40 |
|---|---|
| Market Cap | ₹6,178 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Specialty Care Clinics |
| P/E Ratio | 75.4 |
| Return on Equity | 6.88% |
| 52-Week Range | ₹446.00 – ₹781.50 |
| Beta (1Y) | 0.46 |
| Revenue | ₹282 Cr |
|---|---|
| Net Profit | ₹36 Cr |
| EPS (Basic) | ₹3.19 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Providing Dialysis and Related Healthcare Services-100%
Nephrocare Health Services Limited is trading at ₹602.40, with a market capitalisation of ₹6,178 Cr.
Nephrocare Health Services Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Specialty Care Clinics).
Nephrocare Health Services Limited has a P/E of 75.4 and a return on equity of 6.88%.
In Q1 FY27, Nephrocare Health Services Limited reported revenue of ₹282 Cr and net profit of ₹36 Cr, with basic EPS of ₹3.19 (consolidated, parsed from the company's exchange filing).